Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Researchtranslating…

SEONGNAM, South Korea, Sept. 6, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in the high-efficiency production of circular RNA (circRNA) – a rapidly…

Sign in to join the discussion.

Loading comments…